Jakub Tolar

16.9k total citations · 4 hit papers
270 papers, 10.1k citations indexed

About

Jakub Tolar is a scholar working on Molecular Biology, Cell Biology and Hematology. According to data from OpenAlex, Jakub Tolar has authored 270 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Molecular Biology, 59 papers in Cell Biology and 50 papers in Hematology. Recurrent topics in Jakub Tolar's work include Skin and Cellular Biology Research (48 papers), Hematopoietic Stem Cell Transplantation (41 papers) and Lysosomal Storage Disorders Research (34 papers). Jakub Tolar is often cited by papers focused on Skin and Cellular Biology Research (48 papers), Hematopoietic Stem Cell Transplantation (41 papers) and Lysosomal Storage Disorders Research (34 papers). Jakub Tolar collaborates with scholars based in United States, United Kingdom and Canada. Jakub Tolar's co-authors include Bruce R. Blazar, Paul J. Orchard, Mark J. Osborn, John E. Wagner, Troy C. Lund, Megan Riddle, Steven L. Teitelbaum, Ron McElmurry, Angela Panoskaltsis‐Mortari and Armand Keating and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Jakub Tolar

259 papers receiving 9.9k citations

Hit Papers

Advanced reperfusion strategies for patients with out-of-... 2020 2026 2022 2024 2020 2023 2022 2024 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial
    2020 521 citations Jakub Tolar et al. profile →
  2. Phage-assisted evolution and protein engineering yield compact, efficient prime editors
    2023 161 citations Jordan L. Doman, Smriti Pandey et al. profile →
  3. Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity
    2022 156 citations Amber McElroy, Smriti Pandey et al. profile →
  4. Efficient site-specific integration of large genes in mammalian cells via continuously evolved recombinases and prime editing
    2024 70 citations Smriti Pandey, Xin D. Gao et al. profile →

Peers

Jakub Tolar
Lydia Sorokin Germany
Takahiro Kunisada Japan
David W. Rowe United States
Linzhao Cheng United States
Martin Zenke Germany
Satomi Nishikawa Japan
Edouard G. Stanley Australia
Wolfgang Wagner Germany
Shin-Ichi Nishikawa Japan
Gëorge F. Murphy United States
Lydia Sorokin Germany
Jakub Tolar
Citations per year, relative to Jakub Tolar Jakub Tolar (= 1×) peers Lydia Sorokin

Countries citing papers authored by Jakub Tolar

Since Specialization
Citations

This map shows the geographic impact of Jakub Tolar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakub Tolar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakub Tolar more than expected).

Fields of papers citing papers by Jakub Tolar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakub Tolar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakub Tolar. The network helps show where Jakub Tolar may publish in the future.

Co-authorship network of co-authors of Jakub Tolar

This figure shows the co-authorship network connecting the top 25 collaborators of Jakub Tolar. A scholar is included among the top collaborators of Jakub Tolar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakub Tolar. Jakub Tolar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McDonald-Hyman, Cameron, Christina R. Hartigan, Peter T. Sage, et al.. (2025). Deficiency of T follicular helper cell Tet3 DNA demethylation inhibits pathogenic IgG2c class switching and chronic GVHD. Blood. 145(24). 2813–2827. 1 indexed citations
2.
Yang, Jianbo, Matt A. Price, Colleen L. Forster, et al.. (2024). Chondroitin sulfate proteoglycan 4 increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying transforming growth factor-β signalling. British Journal of Dermatology. 192(1). 104–117. 1 indexed citations
3.
Gao, Xin D., Amber McElroy, Smriti Pandey, et al.. (2024). Twin Prime Editing Mediated Exon Skipping/Reinsertion for Restored Collagen VII Expression in Recessive Dystrophic Epidermolysis Bullosa. Journal of Investigative Dermatology. 144(12). 2764–2777.e9. 5 indexed citations
4.
Eide, Cindy, et al.. (2024). Beyond the Surface: A Narrative Review Examining the Systemic Impacts of Recessive Dystrophic Epidermolysis Bullosa. Journal of Investigative Dermatology. 144(9). 1943–1953. 6 indexed citations
5.
Lee, Catherine, Eric Kofman, Megan Riddle, et al.. (2024). Accelerated Aging and Microsatellite Instability in Recessive Dystrophic Epidermolysis Bullosa–Associated Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology. 144(7). 1534–1543.e2. 1 indexed citations
6.
7.
Niebergall‐Roth, Elke, Natasha Y. Frank, Christoph Ganss, et al.. (2023). ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa. Cytotherapy. 25(7). 782–788. 10 indexed citations
8.
Feser, Colby J., Christopher J. Lees, Daniel Lammers, et al.. (2022). Engineering CRISPR/Cas9 for Multiplexed Recombinant Coagulation Factor Production. International Journal of Molecular Sciences. 23(9). 5090–5090. 1 indexed citations
9.
Ebens, Christen L., John A. McGrath, Douglas R. Keene, et al.. (2020). Immune tolerance of allogeneic haematopoietic cell transplantation supports donor epidermal grafting of recessive dystrophic epidermolysis bullosa chronic wounds*. British Journal of Dermatology. 184(6). 1161–1169. 13 indexed citations
10.
Twaroski, Kirk, et al.. (2020). Leading edge: emerging drug, cell, and gene therapies for junctional epidermolysis bullosa. Expert Opinion on Biological Therapy. 20(8). 911–923. 15 indexed citations
11.
Osborn, Mark J., Gregory A. Newby, Amber McElroy, et al.. (2019). Base Editor Correction of COL7A1 in Recessive Dystrophic Epidermolysis Bullosa Patient-Derived Fibroblasts and iPSCs. Journal of Investigative Dermatology. 140(2). 338–347.e5. 75 indexed citations
12.
Tan, Zhe, Yaming Jiang, Mitra S. Ganewatta, et al.. (2019). Block Polymer Micelles Enable CRISPR/Cas9 Ribonucleoprotein Delivery: Physicochemical Properties Affect Packaging Mechanisms and Gene Editing Efficiency. Macromolecules. 52(21). 8197–8206. 51 indexed citations
13.
Lee, Catherine, Zhuliu Li, John Garbe, et al.. (2018). A multitask clustering approach for single-cell RNA-seq analysis in Recessive Dystrophic Epidermolysis Bullosa. PLoS Computational Biology. 14(4). e1006053–e1006053. 24 indexed citations
14.
Vallera, Daniel A., Martin Felices, Ron McElmurry, et al.. (2016). IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function. Clinical Cancer Research. 22(14). 3440–3450. 295 indexed citations
15.
Webber, Beau R., Michelina Iacovino, Si Ho Choi, et al.. (2013). DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo. Blood. 122(17). 2978–2986. 16 indexed citations
16.
Zhou, Qing, Meghan E. Munger, Steven L. Highfill, et al.. (2010). Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. Blood. 116(14). 2484–2493. 230 indexed citations
17.
Kléma, Jǐŕı, et al.. (2009). Cross-genome knowledge-based expression data fusion. International Conference on Bioinformatics. 43–50. 2 indexed citations
18.
Wagner, Jasenka, Akemi Ishida‐Yamamoto, John A. McGrath, et al.. (2009). Adult stem cells for treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB). Journal of Investigative Dermatology. 129. 4 indexed citations
19.
Tolar, Jakub, Akemi Ishida‐Yamamoto, Megan Riddle, et al.. (2008). Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood. 113(5). 1167–1174. 125 indexed citations
20.
Serafini, Marta, Scott J. Dylla, Masayuki Oki, et al.. (2007). Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells. The Journal of Experimental Medicine. 204(1). 129–139. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lydia Sorokin Breakdown of academic impact, for papers by Takahiro Kunisada Breakdown of academic impact, for papers by David W. Rowe Breakdown of academic impact, for papers by Linzhao Cheng Breakdown of academic impact, for papers by Martin Zenke Breakdown of academic impact, for papers by Satomi Nishikawa Breakdown of academic impact, for papers by Edouard G. Stanley Breakdown of academic impact, for papers by Wolfgang Wagner Breakdown of academic impact, for papers by Shin-Ichi Nishikawa Breakdown of academic impact, for papers by Gëorge F. Murphy
Rankless by CCL
2026